SCHEMBL1334825

SCHEMBL1334825

CCOC(=O)c1cnn(-c2ccccn2)c1Cl

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.74
RAB9A P51151 3/20 0.74
NPC1 O15118 3/20 0.74
TP53 P04637 1/20 0.74
PTGS2 P35354 1/20 0.59
ALDH1A1 P00352 11/20 0.52
MAPT P10636 6/20 0.50
HTT P42858 3/20 0.50
KDM4E B2RXH2 3/20 0.50
GAA P10253 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
TSHR P16473 3/20 0.48
USP2 O75604 1/20 0.48
MEN1 O00255 2/20 0.46
LMNA P02545 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120748 0.87 RAB9A (0.77) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL9601990 0.87 NPC1 (0.55) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL1335629 0.85 NPC1 (1.00) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL10514584 0.85 HPGD (0.74) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL13887597 0.85 HPGD (0.74) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL3725634 0.84 RAB9A (0.55) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL10561345 0.84 NPC1 (0.53) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL27700589 0.84 HPGD (0.72) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL10558823 0.84 RAB9A (0.53) HPGDRAB9ANPC1TP53PTGS2
SCHEMBL10513444 0.84 SMN1; SMN2 (0.54) HPGDRAB9ANPC1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389509-B2 Substituted pyrazole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2013-03-05 US disclosed
US-8389509-B2 Substituted pyrazole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2013-03-05 US disclosed
US-8389509-B2 Substituted pyrazole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2013-03-05 US disclosed
EP-2382211-B1 PYRAZOLE-I, 2, 4 -OXAD IAZOLE DERIVATIVES AS S.PHING0SINE-1-PH0SPHATE AGONISTS BRISTOL MYERS SQUIBB CO (US) 2012-12-19 EP disclosed
EP-2382211-B1 PYRAZOLE-I, 2, 4 -OXAD IAZOLE DERIVATIVES AS S.PHING0SINE-1-PH0SPHATE AGONISTS BRISTOL MYERS SQUIBB CO (US) 2012-12-19 EP disclosed
US-20110275610-A1 SUBSTITUTED PYRAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY 2011-11-10 US disclosed
US-20110275610-A1 SUBSTITUTED PYRAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY 2011-11-10 US disclosed
US-20110275610-A1 SUBSTITUTED PYRAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY 2011-11-10 US disclosed
EP-2382211-A1 PYRAZOLE-I, 2, 4 -OXAD IAZOLE DERIVATIVES AS S.PHING0SINE-1-PH0SPHATE AGONISTS Bristol-Myers Squibb Company (US) 2011-11-02 EP disclosed
WO-2010085584-A1 PYRAZOLE-I, 2, 4 -OXAD IAZOLE DERIVATIVES AS S.PHING0SINE-1-PH0SPHATE AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-29 WO disclosed
WO-2010085584-A1 PYRAZOLE-I, 2, 4 -OXAD IAZOLE DERIVATIVES AS S.PHING0SINE-1-PH0SPHATE AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-29 WO disclosed
EP-0176304-B1 HERBICIDAL PYRAZOLESULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-06-05 EP disclosed
US-4895590-A Herbicidal pyrazolesulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-01-23 US disclosed
US-4881965-A CONTROLLING WILD OATS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1989-11-21 US disclosed
US-4855277-A Thermosensitive recording material having recording layer containing fluorescent dye HOBART CORPORATION (US) 1989-08-08 US disclosed
US-4762550-A Herbicidal pyrazolesulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-08-09 US disclosed
US-4705558-A Herbicidal pyrazolesulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-11-10 US disclosed
EP-0176304-A1 Herbicidal pyrazolesulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1986-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275610-A1 SUBSTITUTED PYRAZOLE COMPOUNDS S1PR3, S1PR1, S1PR4 HPGD 2466/4885RAB9A 1343/4885NPC1 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.